Cite
HARVARD Citation
Shah, P. et al. (2016). Eligibility for Pcsk9 Treatment in 734 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center with Ldl Cholesterol ≥70 Mg/Dl despite Maximal Tolerated Cholesterol Lowering Therapy. Journal of investigative medicine. 64 (4), pp. 931-932. [Online].